Skip to main content
Home

Top menu infoNTD

  • About InfoNTD
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoNTD

  • NTDs [14]
    • Buruli ulcer
    • Chagas disease
    • Dracunculiasis
    • Human African trypanosomiasis
    • Leishmaniasis
    • Leprosy
    • Lymphatic filariasis
    • Mycetoma
    • Onchocerciasis
    • Schistosomiasis
    • Snakebite envenoming
    • Soil-transmitted helminthiasis
    • Trachoma
    • Yaws
  • Cross-cutting issues [13]
    • Data management & analysis [3]
      • Data collection and reporting
      • Mapping
      • Indicators
    • Integrated wound management
    • Capacity strengthening
    • Management of disease complications [2]
      • Medical management
      • Surgical management
    • Prevention of disability [3]
      • Eye care
      • Self-care
      • Disability measurement
    • Physical rehabilitation [3]
      • Physical therapy
      • Orthopaedic footwear
      • Protheses, walking devices and wheelchairs
    • Stigma and mental wellbeing [1]
      • Mental wellbeing project mapping
    • Inclusion [2]
      • Community-based rehabilitation
      • Gender
    • WASH and NTDs
    • Health systems factors
    • Skin-NTDs
    • Preventive Chemotherapy
    • Health education
  • Toolkits [5]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • Perception Study Toolkit (PST)
    • NTD Morbidity and Disability Measurement Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • NTD Toolbox
    • CBM's Community Mental Health Good Practice Guides
  • Online courses

Top menu infoNTD

  • About InfoNTD
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Implementation of community-based rehabilitation in Colombia in mental health: barriers, facilitators, and purposes

Agudelo-Hernández F, Giraldo-Álvarez AB, Marulanda-López E. Oxford University Press (OUP). Community Development Journal. 2024;
Publication

Climate change could fuel urinary schistosomiasis transmission in Africa and Europe.

van der Deure T, Maes T, Huyse T, et al. Global change biology. 2024; 30 (8) : 1-12.
Download PDF
Publication

Theoretical Assessment of Environmental Factors and Untreated Infectious Individuals in the Transmission Dynamics of Buruli ulcer

Yadouleton CC, Tapi MD, Deguenon J, et al. Scientific Research Publishing, Inc.. Applied Mathematics. 2024; 15 (08) : 477-498.
Download PDF
Publication

Global, regional, national epidemiology and trends of neglected tropical diseases in youths and young adults aged 15–39 years from 1990 to 2019: findings from the global burden of disease study 2019

Lv J, Zhang Y, Li X, et al. Springer Science and Business Media LLC. BMC Public Health. 2024; 24 (1) : 1-15.
Download PDF
Publication

Integrated Eco-Health approach significantly reduces helminth infections in endemic Khong islands with emphasis on Schistosoma mekongi

Sayasone S, Vonghachack Y, Xia S, et al. Springer Science and Business Media LLC. Infectious Diseases of Poverty. 2024; 13 (1) : 1-15.
Download PDF
Publication

Compounds Multi-targets against Neglected Diseases

Scotti L, Scotti MT. Bentham Science Publishers Ltd.. Current Drug Targets. 2024; 25 (9) : 575-576.
Download PDF
Publication

Natural Products as Leads for Neglected Trophical Diseases (NTDs) Treatment: A Chemical and Biological - Review

Mathew TS, Chinedu EK, Haladu M, et al. Journal of Sciences and Artificial Intelligence. 2024;
Download PDF
Publication

A health decision analytical model to evaluate the cost-effectiveness of female genital schistosomiasis screening strategies: The female genital schistosomiasis SCREEN framework.

Lamberti O, Terris-Prestholt F, Bustinduy A, et al. Tropical medicine & international health : TM & IH. 2024;
Download PDF
Publication

The Interruption of Transmission of Onchocerciasis in Abia, Anambra, Enugu, and Imo States, Nigeria: The Largest Global Onchocerciasis Stop-Treatment Decision to Date

Ityonzughul C, Sallau A, Miri E, et al. MDPI AG. Pathogens. 2024; 13 (8) : 1-12.
Download PDF
Publication

Treatments and the Perspectives of Developing a Vaccine for Chagas Disease

Farani PSG, Jones KM, Poveda C. MDPI AG. Vaccines. 2024; 12 (8) : 1-20.
Download PDF

Pagination

  • Previous page ‹‹
  • Page 94
  • Next page ››
Subscribe to Full text online

Quick Links

  • Toolbox
  • Publications
  • Organizations
  • NTDs

Support

  • Contact
  • FAQ
  • Privacy statement

Contact us infoNTD

info@InfoNTD.org

(+31) 20 595 0526

     

Stay up to date with the latest developments in NTDs. We share a monthly overview via email showing a selection of the latest NTD publications and tools. 

Subscribe

Related websites:

© 2025 InfoNTD